478149-02-9 Usage
General Description
Thieno[3,2-b]pyridine-2-carboxylic acid methyl ester is a chemical compound with the molecular formula C10H7NO2S. It is a methyl ester derivative of thieno[3,2-b]pyridine-2-carboxylic acid, which is a heterocyclic compound containing a thieno ring fused to a pyridine ring. This chemical is used in the synthesis of pharmaceutical compounds and as a building block in organic chemistry. Its unique structure and properties make it valuable in drug discovery and development, as well as in the study of heterocyclic compounds. Thieno[3,2-b]pyridine-2-carboxylic acid methyl ester has potential applications in the pharmaceutical industry due to its ability to modulate biological targets and potentially treat various medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 478149-02-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,7,8,1,4 and 9 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 478149-02:
(8*4)+(7*7)+(6*8)+(5*1)+(4*4)+(3*9)+(2*0)+(1*2)=179
179 % 10 = 9
So 478149-02-9 is a valid CAS Registry Number.
478149-02-9Relevant articles and documents
MODULATORS OF THE NMDA RECEPTOR
-
Page/Page column 30; 45-46, (2021/01/23)
The present invention is directed to novel modulators of the NMDA receptor. Separate aspects of the inventions are directed to pharmaceutical compositions comprising said compounds and uses of the compounds to treat neurological disorders or neuropsychiatric disorders such as depression.
CERTAIN TRIAZOLOPYRIDINES AND TRIAZOLOPYRAZINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR
-
, (2012/10/08)
Provided are certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor.
Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
-
, (2008/06/13)
The invention provides compounds of Formula I: wherein Azabicyclo is These compounds may be in the form of pharmaceutical salts or compositions, racemic mixtures, or pure enantiomers thereof. The compounds of Formula I are useful in pharmaceuticals in which α7 is known to be involved.
